Personalized Therapy Biosimulation Market Size, Revenue Growth Trends, Company Strategy Analysis, 2021–2028
The global personalized
therapy biosimulation market size reached USD 1,061.7 Million in 2020
and is expected to register a revenue CAGR of 14.6%, during the forecast
period, according to latest analysis by Emergen Research. Rising incidence of
drug relapse and drug resistance cases and increasing application of
quantitative system pharmacology in drug development processes are some key
factors driving global personalized therapy biosimulation market revenue
growth.
Drug development is a lengthy, complex, multifaceted, and
costly process, with high failure rates and fewer number of drugs receiving
U.S. Food & Drug Administration (FDA) approval. The low success rate,
increasing R&D expenditure, rising incidence of drug resistance in cancer,
epilepsy, and tuberculosis among others are some factors driving rising need
for incorporating biosimulation technique for the development of new generation
of drugs. Majority of patients show resistance to novel targeted drugs or
classical chemotherapeutic agents and do not respond to standard cancer
treatment options such as chemotherapy and radiation therapy, thereby leading
to higher cancer recurrence rate.
Quantitative Systems Pharmacology (QSP), which is relatively
a new discipline in biomedical research,
utilizes mathematical computer models for characterizing disease process,
biological system and drug pharmacology, and is increasingly incorporated in
early stages in drug discovery to late-stage development and life-cycle
management. QSP enables evaluation of critical aspects related to the efficacy
of a drug candidate and designing of Phase 2 clinical studies to significantly
improve clinical outcomes. Increasing implementation of quantitative systems
pharmacology will significantly increase R&D productivity of pharmaceutical
and biotechnology companies which is expected to boost revenue growth of the
market.
Download Sample PDF
Copy of this Report to understand structure of the complete report (Including
Full TOC, Table & Figures)@ https://www.emergenresearch.com/request-sample/785
Looking for more information on this Personalized Therapy
Biosimulation Market reports click @ https://www.emergenresearch.com/industry-report/personalized-therapy-biosimulation-market
Personalized Therapy Biosimulation Market : Competitive
Landscape
Rising strategic collaborations between significant players
of the Personalized Therapy Biosimulation Market is expanding the market scope
and is one of the key business strategies adopted by the prominent players.
Manufacturers and vendors in emerging countries are actively investing in the
market to develop advanced technology, which is, in turn, expected to
drive the growth of the market over the projected period.
Some major players in the market research report include,
Cellworks Group Inc., Certara USA Inc., Simulation Plus Inc.,
Schrodinger Inc., In Silico Biosciences Inc., Genedata AG, Physiomics plc,
Insilico Biotechology AG, Chemical Computing Group ULC (CCG), and Evidera Inc.
Key Benefits of the Report:
Comprehensive analysis of the competitive scenario and its
changing dynamics
Analytical data with detailed SWOT analysis and Porter’s
Five Forces analysis
In-depth 8-year analysis of the Global Personalized Therapy
Biosimulation Market
Critical understanding of the key market segments
Comprehensive analysis of the drivers, restraints, trends,
and opportunities
Detailed regional analysis and extensive company profiling
Extensive assessment of current and emerging trends of the
market
The report, additionally, offers a comprehensive SWOT
analysis and Porter’s Five Forces analysis to offer a better understanding of
the competitive landscape of the industry. It also covers strategies adopted by
prominent players such as mergers and acquisitions, collaborations, joint
ventures, product launches, and brand promotions, among others. The report aims
to offer the readers a holistic understanding of the relevant features of the
industry.
Emergen Research has segmented the global personalized
therapy biosimulation market on the basis of product, therapeutic area,
application end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
Software
Services
Therapeutic Area Outlook (Revenue, USD Billion;
2018–2028)
Oncology
Others
Personalized Therapy
Biosimulation Market Reports inquiry and request for customization @ https://www.emergenresearch.com/request-for-customization/785
Application Outlook (Revenue, USD Billion; 2018–2028)
Drug Development
Drug Discovery
Others
Personalized Therapy Biosimulation Market Segmentation based
on Regions:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Spain, Benelux, Rest
of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia
Pacific)
Latin America (Brazil, Rest of Latin America)
Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest
of Middle East & Africa)
Table of Contents:
Report
Overview: It includes the objectives and scope of the study and gives
highlights of key market segments and players covered. It also includes years
considered for the research study.
Executive Summary: It
covers industry trends with high focus on market use cases and top market
trends, market size by regions, and global market size. It also covers market
share and growth rate by regions.
Key
Players: Here, the report concentrates on mergers and acquisitions,
expansions, analysis of key players, establishment date of companies, and areas
served, manufacturing base, and revenue of key players.
Breakdown by Product
and Application: This section provides details about market size by
product and application.
Regional
Analysis: All of the regions and countries analyzed in the report are
studied on the basis of market size by product and application, key players,
and market forecast.
Profiles of
International Players: Here, players are evaluated on the basis of their
gross margin, price, sales, revenue, business, products, and other company
details.
Market
Dynamics: It includes supply chain analysis, analysis of regional
marketing, challenges, opportunities, and drivers analyzed in the report.
Appendix: It
includes details about research and methodology approach, research methodology,
data sources, authors of the study, and a disclaimer.
Buy Exclusive Copy@ https://www.emergenresearch.com/select-license/785
Take a Look at our other Reports:
Medical Smart Textiles Market
Robotics Surgical Simulation Systems
Market
Increasing Applications of DNA Origami
in the Manufacture of Drug Delivery Systems is a Key Factor Driving DNA Origami
Market
Topical Drug Delivery Market
Advanced Prosthetics and Exoskeletons
Market
Ultrasound-Guided Regional Anesthesia
Market
Medical Wearable Market
Ambulatory EHR Market
About Us:
At Emergen Research, we believe in advancing with
technology. We are a growing market research and strategy consulting company
with an exhaustive knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted to become more prevalent in
the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence
services | Growth Consulting
Services
Comments
Post a Comment